The Maryland-based firm said that the money will support the development and commercialization of a screening test for esophageal squamous cell carcinoma.
Good day, everyone and welcome to the Moody's Corporation Third Quarter 2024 Earnings Call. At this time, I would like to inform you that this conference is being recorded and that all participants ...